{"id":"contrast-agent-iopromide","safety":{"commonSideEffects":[{"rate":null,"effect":"Contrast-induced nephropathy"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Flushing and warmth sensation"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL1725","moleculeType":"Small molecule","molecularWeight":"791.11"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iopromide contains iodine atoms that absorb X-rays, creating contrast between different tissue densities on radiographic images. It is administered intravenously and distributes through the vasculature and extracellular space, allowing enhanced visualization of blood vessels, organs, and tissues during angiography, CT, and other imaging procedures. As a non-ionic contrast agent, it has lower osmolality than ionic agents, reducing the risk of adverse reactions.","oneSentence":"Iopromide is a non-ionic iodinated contrast agent that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:43:49.512Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contrast enhancement for angiography and vascular imaging"},{"name":"Contrast enhancement for computed tomography (CT) imaging"},{"name":"Contrast enhancement for urography and other radiographic procedures"}]},"trialDetails":[{"nctId":"NCT07391787","phase":"","title":"Low-acid Contrast Media for Preventing Post ERCP Pancreatitis","status":"COMPLETED","sponsor":"Shandong University","startDate":"2025-08-01","conditions":"Post-ERCP Acute Pancreatitis","enrollment":3979},{"nctId":"NCT06475066","phase":"NA","title":"Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-07-01","conditions":"Breast Cancer","enrollment":320},{"nctId":"NCT04561739","phase":"NA","title":"Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital","startDate":"2021-02-01","conditions":"De Novo Stenosis, Coronary Artery Disease","enrollment":2272},{"nctId":"NCT05428397","phase":"","title":"A Study, Called UV Population, to Learn More About the Safety of the Study Drug Ultravist, Which is Given to Get Clearer X-ray Pictures, in People of Different Sexes, Races, and From Different Countries/Regions","status":"COMPLETED","sponsor":"Bayer","startDate":"2022-06-30","conditions":"Contrast Enhanced X-ray Based Examination","enrollment":152233},{"nctId":"NCT06033573","phase":"NA","title":"Preoperative Assessment of Pathological Nipple Discharge With Delayed Ductal Imaging of Contrast-enhanced Mammography","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2023-08-01","conditions":"Nipple Discharge","enrollment":60},{"nctId":"NCT01943643","phase":"NA","title":"Multislice CT Angiography of Coronary Bifurcations and Outcomes After Intervention","status":"COMPLETED","sponsor":"Clinical Hospital Center Zemun","startDate":"2013-09","conditions":"Coronary Artery Disease","enrollment":70},{"nctId":"NCT05786846","phase":"","title":"Serum Thyroid Function After Iodinated Contrast Administration","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-02-15","conditions":"Thyroid Dysfunction","enrollment":400},{"nctId":"NCT01140204","phase":"PHASE1, PHASE2","title":"Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media","status":"COMPLETED","sponsor":"University Hospital, Saarland","startDate":"2003-03","conditions":"Coronary Artery Disease","enrollment":32},{"nctId":"NCT05778929","phase":"","title":"Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2023-04-01","conditions":"Pancreatitis, Chronic","enrollment":694},{"nctId":"NCT05729490","phase":"NA","title":"Techniques and Pitfalls of Multi-Slice CT Coronary Angiography","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-01-01","conditions":"Computed Tomography Angiography, Coronary Artery Disease","enrollment":60},{"nctId":"NCT05666375","phase":"NA","title":"Percutaneous Translumbar Vs Transhepatic Permcath","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-01","conditions":"End Stage Renal Disease","enrollment":52},{"nctId":"NCT03631771","phase":"PHASE4","title":"Pediatric Risk of Hypothyroidism With Iodinated Contrast Media","status":"WITHDRAWN","sponsor":"GE Healthcare","startDate":"2022-03","conditions":"Hypothyroidism","enrollment":""},{"nctId":"NCT04605471","phase":"","title":"A Study to Learn More About the Safety of Ultravist in Children and in the Elderly","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-10-31","conditions":"Hypersensitivity","enrollment":132850},{"nctId":"NCT03622801","phase":"","title":"Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-10-12","conditions":"Contrast Medium","enrollment":133331},{"nctId":"NCT03179592","phase":"","title":"VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-03-22","conditions":"Coronary Artery Disease, Cardiovascular Diseases","enrollment":120},{"nctId":"NCT00335101","phase":"PHASE4","title":"Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography","status":"WITHDRAWN","sponsor":"GE Healthcare","startDate":"2006-06","conditions":"Coronary Artery Disease (CAD), Renal Impairment, Diabetes Mellitus","enrollment":""},{"nctId":"NCT03292354","phase":"NA","title":"Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2017-04-11","conditions":"Coronary Artery Calcification, Cardiac Disease","enrollment":327},{"nctId":"NCT02840903","phase":"","title":"A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-07-26","conditions":"Angiography, Multidetector Computed Tomography","enrollment":1214},{"nctId":"NCT03448302","phase":"","title":"Computed Tomography Perfusion Colorectal Cancer With Tumor Grade","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-03-10","conditions":"Colo-rectal Cancer","enrollment":50},{"nctId":"NCT01607489","phase":"NA","title":"Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2011-06","conditions":"Pulmonary Arterial Hypertension","enrollment":25},{"nctId":"NCT01829672","phase":"NA","title":"Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2013-03","conditions":"Pulmonary Arterial Hypertension","enrollment":55},{"nctId":"NCT03110068","phase":"","title":"Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Ming Kuang","startDate":"2017-04-10","conditions":"Hepatocellular Carcinoma","enrollment":370},{"nctId":"NCT01255722","phase":"PHASE4","title":"Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-11","conditions":"Coronary Artery Disease","enrollment":468},{"nctId":"NCT01580046","phase":"PHASE4","title":"Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction","status":"UNKNOWN","sponsor":"Yong Huo","startDate":"2012-04","conditions":"Kidney Failure, Chronic","enrollment":200},{"nctId":"NCT01114295","phase":"NA","title":"Computed Tomography Enterography (CTE) Versus Capsule Endoscopy for Overt, Obscure Gastrointestinal (GI) Bleeding","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2010-03","conditions":"Recurrent Gastrointestinal Bleeding","enrollment":""},{"nctId":"NCT00724659","phase":"NA","title":"Pre and Post Arthrogram Ultrasound Images of Joints","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2004-09","conditions":"Joint Abnormalities","enrollment":9},{"nctId":"NCT00926562","phase":"PHASE4","title":"A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2009-02","conditions":"Kidney Failure, Chronic","enrollment":592},{"nctId":"NCT00876083","phase":"","title":"PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-03","conditions":"Diagnostic Imaging","enrollment":44920},{"nctId":"NCT00827788","phase":"PHASE4","title":"Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Ospedale San Donato","startDate":"2008-12","conditions":"Contrast Induced Nephropathy, Acute Myocardial Infarction","enrollment":432},{"nctId":"NCT00823628","phase":"PHASE4","title":"Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2009-02","conditions":"Chronic Renal Insufficiency, Coronary Angiography","enrollment":420},{"nctId":"NCT00154648","phase":"PHASE4","title":"CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2005-06","conditions":"Angiography, Digital Subtraction, Magnetic Resonance Angiography","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":38,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"contrast agent (iopromide)","genericName":"contrast agent (iopromide)","companyName":"Seoul National University Bundang Hospital","companyId":"seoul-national-university-bundang-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iopromide is a non-ionic iodinated contrast agent that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures. Used for Contrast enhancement for angiography and vascular imaging, Contrast enhancement for computed tomography (CT) imaging, Contrast enhancement for urography and other radiographic procedures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}